AA
ELOS

AQR Arbitrage’s Syneron Medical Ltd ELOS Stock Holding History

AQR Arbitrage’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,479,055
Closed -$16.2M – 383
2017
Q2 		$16.2M Buy
+1,479,055
New +$16.2M 0.18% 133

Other funds holding ELOS

BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $449M AUM 51.52% 1-Year Est. Return

AQR Arbitrage's ELOS Position: Q3 2017 in Review

AQR Arbitrage sold out of Syneron Medical Ltd (ELOS) in Q3 2017, closing a stake of 1,479,055 shares — an estimated $16.2M sold.

AQR Arbitrage first reported a position in ELOS in Q2 2017 and held it in 1 quarter. The position peaked at $16.2M in Q2 2017. 3 funds tracked by Wall St. Rank hold ELOS as of Q3 2017.

  • AQR Arbitrage reported no remaining Syneron Medical Ltd position as of Q3 2017 after selling out during the quarter.
  • AQR Arbitrage sold 1,479,055 Syneron Medical Ltd shares in Q3 2017, an estimated $16.2M.
  • AQR Arbitrage first reported a position in Syneron Medical Ltd in Q2 2017 and held it in 1 quarter.
  • AQR Arbitrage's Syneron Medical Ltd position peaked at $16.2M in Q2 2017.
  • 3 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q3 2017.

Based on AQR Arbitrage's 13F filing for Q3 2017, filed 14 Nov 2017.